FDMT
4D Molecular Therapeutics, Inc. Common StockRecent alerts on FDMT
All signals →
News
4dMT Revenue Jumps 200 Percent in Q2
14d ago
News
4D Molecular Therapeutics tumbles following mid-stage clinical study results - Investing.com
14d ago
News
4d Molecular Therapeutics CEO sells $290k in stock - Investing.com
14d ago
News
4D Molecular Therapeutics officer sells $90,757 in stock By Investing.com - Investing.com Australia
14d ago
News
Assessing 4D Molecular Therapeutics: Insights From 7 Financial Analysts
14d ago
News
Goldman Sachs Optimistic About Regenxbio's Gene Therapy Pipeline, Sees Over 160% Upside
14d ago
Insider trade
Sale by Ashoo Gupta (VP, Finance and Controller)
69d ago
SEC filing
FDMT Reports $118M Cash Raise, $514M Balance Sheet, 4FRONT-1 Enrollment Complete, Topline Data H1 2027
75d ago
News
BHM 2025 Tax Reporting Information For 2025 Dividends
123d ago
News
US Stocks Climb as Markets Eye Tech Earnings, Fed Meeting | Closing Bell
126d ago
News
4DMT Announces Exclusive License Agreement with Otsuka Pharmaceutical Co., Ltd. for Development and Commercialization of 4D-150 in Asia-Pacific
153d ago
News
4DMT Appoints Kristian Humer as Chief Financial Officer
155d ago
News
Why Everyone Is Watching 4D Molecular Therapeutics, Inc. (FDMT) Closely
156d ago
Scanner
Unusual volume (z=4.2)
160d ago
Scanner
Unusual volume (z=4.5)
161d ago
Scanner
Unusual volume (z=4.5)
163d ago
Scanner
Unusual volume (z=4.5)
164d ago
Scanner
Unusual volume (z=6.5)
165d ago
Short volume
Short volume 53% of volume (5.6σ)
168d ago
Get push alerts for FDMT
Add it to your watchlist in the app and receive every signal the moment it fires.
Download for iOS